(PRWEB) February 14, 2015
Over the years the demand for whole exome sequencing instruments, kits and services is likely to increase. Factors such as the rapidly decreasing costs of sequencing, adoption of WES technology by new consumers, strategic alliances amongst key players and research institutes and increase in utilization of WES technology for new scientific applications are driving this demand for whole exome sequencing. The most important factor increasing the preference of WES over whole genome sequencing is its low-cost sequencing capability. However a lack of skilled professionals and high reliability on government grants are some of the factors hindering the growth of the WES market.
This report studies the global Whole Exome Sequencing (WES) market over the forecast period of 2013–2018. This market was valued at $ 326.6 million in 2013 and is poised to grow at a CAGR of 22%, to reach $ 884.1 million by 2018.
The global Whole Exome Sequencing Market is segmented on the basis of technology, products and services, applications, end users and geography. Based on technology, the Whole Exome Sequencing Market is divided between sequencing by synthesis and sequencing by ion semiconductor. Based on products and services the Whole Exome Sequencing Market comprises instruments/platforms/sequencers, kits, sequencing services and data analysis services. Whole exome sequencing kits are further classified into DNA fragmentation, end repair, A-Tailing and size selection, library preparation kits and target enrichment kit.
Based on applications the Whole Exome Sequencing Market is segmented into diagnostics, drug discovery and development, personalized medicine and agriculture and animal research, among others. The market by end users is classified into research centres, academic and government institutions, hospitals and clinics and pharmaceutical and biotechnology companies.
Based on geography the market is divided into North America, Europe, Asia and Rest of the World (RoW). North America is the largest market for whole exome sequencing followed by Europe and Asia. The Asian market is slated to grow at the highest rate over the next five years.
Major players in the global Whole Exome Sequencing Market include Illumina, Inc. (U.S.) Life Technologies (acquired by Thermo Fisher Scientific, Inc.) (U.S.), Roche NimbleGen, Inc. (U.S.), Agilent Technologies (U.S.), BGI (Beijing Genomics Institute, China), Eurofins Genomics, Inc. (Germany), Sengenics (U.S.), GENEWIZ, Inc. (U.S.), Knome, Inc. (U.S.), Macrogen, Inc. (South Korea) and Ambry Genetics (U.S.), among others.
MarketsandMarkets is world’s No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the “Growth Engagement Model – GEM”. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write “Attack, avoid and defend” strategies, identify sources of incremental revenues for both the company and its competitors.
M&M’s flagship competitive intelligence and market research platform, “RT” connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.
North – Dominion Plaza,
17304, Preston Road,
Suite 800, Dallas, TX 75252
Visit MarketsandMarkets Blog http://www.marketsandmarketsblog.com/market-reports/healthcare/biotechnology
Find More Genomics Press Releases